Daniel G. Welch - Apr 3, 2023 Form 4/A - Amendment Insider Report for Seagen Inc. (SGEN)

Role
Director
Signature
By: /s/ Jennifer Prosba For: Daniel G. Welch
Stock symbol
SGEN
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/12/2023, 08:03 PM
Date Of Original Report
Apr 5, 2023
Previous filing
Mar 17, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SGEN Common Stock 4.15K Apr 3, 2023 Direct F1, F2
holding SGEN Common Stock 12.3K Apr 3, 2023 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This amendment to the Form 4 originally filed on April 5, 2023 is being filed solely to check the Rule 10b5-1(c) Transaction Indication box and provide related disclosure. Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.